NCT04997369View on ClinicalTrials.gov

Catheterless Water Vapor Therapy for the Treatment of BPH

NASuspendedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 13, 2021

Primary Completion Date

June 21, 2024

Study Completion Date

June 30, 2027

Conditions
Benign Prostatic Hyperplasia
Interventions
DEVICE

Rezum

The Rezum system is an ablative procedure for patients with benign prostatic hyperplasia (BPH).

Trial Locations (1)

10065

Weill Cornell Medicine, New York

Sponsors

Lead Sponsor

Northwell Health
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Northwell Health

OTHER